by rnossadmin | Jun 10, 2024 | Uncategorized
Decoding the MSSG’s New Recommendations The European Medicines Agency’s Medicines Shortages Steering Group (MSSG) has developed recommendations to ensure the availability and supply of critical human medicines with identified supply chain...
by rnossadmin | Jun 10, 2024 | Uncategorized
A qualitative study involving 63 participants examined their experiences with REMS (Risk Evaluation and Mitigation Strategies) programs associated with four specific drugs: Natalizumab, Riociguat, Sodium Pxybate, and Vigabatrin. While many participants found...
by rnossadmin | Jun 10, 2024 | Uncategorized
What is Chikungunya (CHIKV)? Chikungunya Virus, also known as CHIKV, is a mosquito-borne viral disease that has been reported in over 110 countries. The name comes from the African Kimakonde language and roughly translates to, “To become contorted”, in...
by rnossadmin | Mar 12, 2024 | Uncategorized
As the fight against COVID-19 continues, the efficacy and safety of vaccines remain critical considerations. Recent studies shed light on both fronts, offering valuable insights into vaccine effectiveness and potential adverse events. Vaccine Effectiveness in...
by rnossadmin | Mar 11, 2024 | Uncategorized
In the labyrinth of modern medicine, adverse drug reactions (ADRs) stand as formidable challenges, often shrouded in mystery and uncertainty. For patients, navigating the landscape of ADRs can be daunting, with limited information available beyond the basics of nature...
by cwsadmin | Feb 9, 2024 | Uncategorized
Machine learning and artificial intelligence seem to have dipped into almost every industry in the world; fashion, marketing, manufacturing, engineering and even commercial real estate. So, while it’s not hard to fathom that machine learning could soon leak...
